USANA Health Sciences Updates Financial Outlook with $900M Net Sales Target
USANA Health Sciences (NYSE: USNA) has provided an updated financial outlook, projecting net sales to approach $900 million. The company also expects adjusted EBITDA to reach approximately $77 million as it continues its strategic transition from a single-channel model toward a more diversified distribution strategy. CEO and Executive Chairman Kevin Guest characterized the recent quarter as mixed but expressed optimism regarding the progress of the company's long-term evolution. This strategic shift aims to expand USANA's market reach beyond its traditional channels to drive sustainable growth.
Tickers: $USNA
Topics: corporate strategy earnings call quarterly results
Read the full article at Seeking Alpha
Part of the story USANA HEALTH SCIENCES INC - 8-K Filing (4 articles)